HK Stock MarketDetailed Quotes

01789 AK MEDICAL

Watchlist
  • 5.130
  • -0.190-3.57%
Market Closed Nov 12 16:08 CST
5.76BMarket Cap27.88P/E (TTM)

AK MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
Turnover
1.30%657.1M
3.97%1.09B
22.11%648.69M
38.17%1.05B
18.67%531.21M
-26.46%761.44M
-6.54%447.63M
11.73%1.04B
9.41%478.98M
54.31%926.71M
Operating income
1.30%657.1M
3.97%1.09B
22.11%648.69M
38.17%1.05B
18.67%531.21M
-26.46%761.44M
-6.54%447.63M
11.73%1.04B
9.41%478.98M
54.31%926.71M
Cost of sales
-4.65%-258.62M
-0.91%-419.38M
-28.26%-247.12M
-58.48%-415.61M
-38.32%-192.68M
18.26%-262.25M
2.35%-139.3M
-13.19%-320.85M
-7.10%-142.66M
-47.88%-283.45M
Operating expenses
-4.65%-258.62M
-0.91%-419.38M
-28.26%-247.12M
-58.48%-415.61M
-38.32%-192.68M
18.26%-262.25M
2.35%-139.3M
-13.19%-320.85M
-7.10%-142.66M
-47.88%-283.45M
Gross profit
-0.77%398.48M
5.98%674.49M
18.62%401.57M
27.49%636.44M
9.80%338.54M
-30.14%499.19M
-8.32%308.33M
11.08%714.53M
10.42%336.32M
57.32%643.25M
Selling expenses
3.75%-113.01M
-21.49%-218.81M
-17.74%-117.41M
3.86%-180.11M
-26.67%-99.71M
-21.57%-187.35M
-25.45%-78.72M
12.11%-154.1M
25.66%-62.75M
-42.69%-175.33M
Administrative expenses
3.81%-72.31M
-12.79%-133.44M
-37.84%-75.17M
-12.34%-118.31M
-6.86%-54.54M
-26.86%-105.32M
-33.39%-51.04M
9.96%-83.02M
19.55%-38.26M
-24.39%-92.2M
Research and development expenses
4.15%-63.58M
-23.69%-137.13M
-21.92%-66.33M
1.95%-110.87M
-5.15%-54.4M
-7.71%-113.07M
-17.85%-51.74M
-30.36%-104.97M
-24.95%-43.9M
-76.61%-80.53M
Impairment and provision
----
----
----
---18.36M
----
----
----
---8.85M
----
----
-Goodwill impairment
----
----
----
---18.36M
----
----
----
---8.85M
----
----
Special items of operating profit
177.10%2.9M
135.59%26.37M
-78.85%1.05M
87.21%11.19M
138.27%4.96M
12.11%5.98M
120.57%2.08M
-73.77%5.33M
-93.93%943K
311.37%20.33M
Operating profit
6.11%152.49M
-3.86%211.48M
6.58%143.71M
121.23%219.98M
4.60%134.84M
-73.05%99.44M
-32.98%128.92M
16.93%368.93M
25.71%192.36M
84.27%315.52M
Financing income
-29.75%10.03M
-3.31%19.63M
-2.28%14.28M
122.59%20.31M
442.55%14.61M
18.77%9.12M
-40.35%2.69M
30.61%7.68M
31.44%4.52M
79.68%5.88M
Earning before tax
2.87%162.52M
-3.82%231.12M
5.71%157.99M
121.35%240.29M
13.56%149.45M
-71.17%108.56M
-33.15%131.61M
17.18%376.61M
25.84%196.87M
84.18%321.4M
Tax
8.43%-23.27M
-37.99%-49.01M
-8.51%-25.41M
-122.82%-35.52M
-16.35%-23.42M
74.54%-15.94M
40.80%-20.13M
-15.05%-62.6M
-26.42%-34M
-84.04%-54.41M
After-tax profit from continuing operations
5.04%139.25M
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
Earning after tax
5.04%139.25M
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
Profit attributable to shareholders
5.04%139.25M
-11.07%182.1M
5.19%132.57M
121.09%204.77M
13.05%126.03M
-70.50%92.62M
-31.55%111.48M
17.61%314.01M
25.72%162.87M
84.21%266.99M
Basic earnings per share
0.00%0.12
-11.11%0.16
9.09%0.12
125.00%0.18
10.00%0.11
-71.43%0.08
-33.33%0.1
7.69%0.28
25.00%0.15
85.71%0.26
Diluted earnings per share
0.00%0.12
-11.11%0.16
9.09%0.12
125.00%0.18
10.00%0.11
-71.43%0.08
-33.33%0.1
12.00%0.28
25.00%0.15
78.57%0.25
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
KPMG
--
KPMG
--
KPMG
--
KPMG
--
KPMG
(Q6)Jun 30, 2024 (FY)Dec 31, 2023 (Q6)Jun 30, 2023 (FY)Dec 31, 2022 (Q6)Jun 30, 2022 (FY)Dec 31, 2021 (Q6)Jun 30, 2021 (FY)Dec 31, 2020 (Q6)Jun 30, 2020 (FY)Dec 31, 2019
Turnover 1.30%657.1M 3.97%1.09B 22.11%648.69M 38.17%1.05B 18.67%531.21M -26.46%761.44M -6.54%447.63M 11.73%1.04B 9.41%478.98M 54.31%926.71M
Operating income 1.30%657.1M 3.97%1.09B 22.11%648.69M 38.17%1.05B 18.67%531.21M -26.46%761.44M -6.54%447.63M 11.73%1.04B 9.41%478.98M 54.31%926.71M
Cost of sales -4.65%-258.62M -0.91%-419.38M -28.26%-247.12M -58.48%-415.61M -38.32%-192.68M 18.26%-262.25M 2.35%-139.3M -13.19%-320.85M -7.10%-142.66M -47.88%-283.45M
Operating expenses -4.65%-258.62M -0.91%-419.38M -28.26%-247.12M -58.48%-415.61M -38.32%-192.68M 18.26%-262.25M 2.35%-139.3M -13.19%-320.85M -7.10%-142.66M -47.88%-283.45M
Gross profit -0.77%398.48M 5.98%674.49M 18.62%401.57M 27.49%636.44M 9.80%338.54M -30.14%499.19M -8.32%308.33M 11.08%714.53M 10.42%336.32M 57.32%643.25M
Selling expenses 3.75%-113.01M -21.49%-218.81M -17.74%-117.41M 3.86%-180.11M -26.67%-99.71M -21.57%-187.35M -25.45%-78.72M 12.11%-154.1M 25.66%-62.75M -42.69%-175.33M
Administrative expenses 3.81%-72.31M -12.79%-133.44M -37.84%-75.17M -12.34%-118.31M -6.86%-54.54M -26.86%-105.32M -33.39%-51.04M 9.96%-83.02M 19.55%-38.26M -24.39%-92.2M
Research and development expenses 4.15%-63.58M -23.69%-137.13M -21.92%-66.33M 1.95%-110.87M -5.15%-54.4M -7.71%-113.07M -17.85%-51.74M -30.36%-104.97M -24.95%-43.9M -76.61%-80.53M
Impairment and provision ---- ---- ---- ---18.36M ---- ---- ---- ---8.85M ---- ----
-Goodwill impairment ---- ---- ---- ---18.36M ---- ---- ---- ---8.85M ---- ----
Special items of operating profit 177.10%2.9M 135.59%26.37M -78.85%1.05M 87.21%11.19M 138.27%4.96M 12.11%5.98M 120.57%2.08M -73.77%5.33M -93.93%943K 311.37%20.33M
Operating profit 6.11%152.49M -3.86%211.48M 6.58%143.71M 121.23%219.98M 4.60%134.84M -73.05%99.44M -32.98%128.92M 16.93%368.93M 25.71%192.36M 84.27%315.52M
Financing income -29.75%10.03M -3.31%19.63M -2.28%14.28M 122.59%20.31M 442.55%14.61M 18.77%9.12M -40.35%2.69M 30.61%7.68M 31.44%4.52M 79.68%5.88M
Earning before tax 2.87%162.52M -3.82%231.12M 5.71%157.99M 121.35%240.29M 13.56%149.45M -71.17%108.56M -33.15%131.61M 17.18%376.61M 25.84%196.87M 84.18%321.4M
Tax 8.43%-23.27M -37.99%-49.01M -8.51%-25.41M -122.82%-35.52M -16.35%-23.42M 74.54%-15.94M 40.80%-20.13M -15.05%-62.6M -26.42%-34M -84.04%-54.41M
After-tax profit from continuing operations 5.04%139.25M -11.07%182.1M 5.19%132.57M 121.09%204.77M 13.05%126.03M -70.50%92.62M -31.55%111.48M 17.61%314.01M 25.72%162.87M 84.21%266.99M
Earning after tax 5.04%139.25M -11.07%182.1M 5.19%132.57M 121.09%204.77M 13.05%126.03M -70.50%92.62M -31.55%111.48M 17.61%314.01M 25.72%162.87M 84.21%266.99M
Profit attributable to shareholders 5.04%139.25M -11.07%182.1M 5.19%132.57M 121.09%204.77M 13.05%126.03M -70.50%92.62M -31.55%111.48M 17.61%314.01M 25.72%162.87M 84.21%266.99M
Basic earnings per share 0.00%0.12 -11.11%0.16 9.09%0.12 125.00%0.18 10.00%0.11 -71.43%0.08 -33.33%0.1 7.69%0.28 25.00%0.15 85.71%0.26
Diluted earnings per share 0.00%0.12 -11.11%0.16 9.09%0.12 125.00%0.18 10.00%0.11 -71.43%0.08 -33.33%0.1 12.00%0.28 25.00%0.15 78.57%0.25
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards IAS IAS IAS IAS IAS IAS IAS IAS IAS IAS
Audit Opinions -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion -- Unqualified Opinion
Auditor -- KPMG -- KPMG -- KPMG -- KPMG -- KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data